Pakistan Science Abstracts
Article details & metrics
No Detail Found!!
The Sterategic Role of Fibroblast Growth Factor-21in Obesity.
Author(s):
1. Mir Hassan Khoso: Biopharmaceutical Lab, School of Life Science, Northeast Agricultural University, Harbin, P.R.China
2. Meng Fanrui: Biopharmaceutical Lab, School of Life Science, Northeast Agricultural University, Harbin, P.R.China
3. Lubna Muhi Rasoul: College of Science, University of Baghdad, Baghdad, Iraq
4. WenFei Wang: Biopharmaceutical Lab, School of Life Science, Northeast Agricultural University, Harbin, P.R.China
5. Muneer Ahmed Khoso: Northeast Forestry University, Harbin, P.R.China
6. Yeboah Kwaku Opoku: Biopharmaceutical Lab, School of Life Science, Northeast Agricultural University, Harbin, P.R.China
7. Amro Abdelazez: Key Laboratory of Dairy Science of Ministry of Education, Northeast Agricultural University, Harbin,
8. Sajjad Hussain: Department of Microbiology, Harbin Medical University, Harbin, P.R, China
9. Deshan Li: Biopharmaceutical Lab, School of Life Science, Northeast Agricultural University, Harbin, P.R.China
Abstract:
Due to obesity many risk factors arise, such as Type 2 Diabetes, Impaired Glucose Tolerance dyslipidemia, hypertension and metabolic homeostasis and disorder. FGF21 is a key regulating endocrine, lipid metabolism, glucose metabolism. Fibroblast growth factor-21 improves glucose tolerance in obese mice, lowers serum free fatty acids (FFA) & results in weight loss. The FGF-21 in obese & diabetes rodent models create confirmatory metabolic variations which consist of dyslipidemia, hyperglycemia, and a decrease in body weight achieved by insulin sensitivity, glucose uptake in peripheral tissues, rise in energy consumption, fat usage, reducing the production of glucagon on the islet of alpha cells. However, FGF-21 rectifies several metabolic complications and has a promising strategic role in therapeutic aim for treatment of obesity, T2DM, dyslipidemia and other related metabolic complications
Page(s): 855-864
DOI: DOI not available
Published: Journal: Pakistan Journal of Biotechnology, Volume: 15, Issue: 3, Year: 2018
Keywords:
Keywords are not available for this article.
References:
[1] Berti , L.,Irmler , M.,Zdichavsky , M.,Meile , T.,Böhm , A.,Stefan , N.,Fritsche , A .,Beckers , J.,Königsrainer .A., Ulrich,Häring,Staiger, .Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes, -
[2] .Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians,Diabetes Care 36 145 -149-2013
[3] CAdams,A. , Kharitonenkov,A., 2012.FGF21: The center of a transcriptional nexus in metabolic regulation,Current diabetes reviews 8 285 -293
[4] Cao , S. S., 2014.Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease,Antioxidants & redox signaling 21 396 -413
[5] Chartoumpekis , D. V.,Zaravinos , A.,Ziros , P. G.,Iskrenova , R. P.,Psyrogiannis , A. I.,Kyriazopoulou , V. E.,Habeos , I.G., 2012.Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice,PLoS One 7 -
[6] 2010.Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1- PGC-1α pathway,Proceedings of the National Academy of Sciences 107 12553 -12558
[7] Chen,Li , L.,Yang,Li , K.,Qi,Zhu , W.,Tang , Y.,Liu , H.,Boden , G., 2008.Circulating FGF21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus,Experimental and Clinical Endocrinology & Diabetes 116 65 -68
[8] Choi , S. H.,Hong , E. S.,Lim , S., 2013.Clinical implications of adipocytokines and newly emerging metabolic factors with relation to insulin resistance and cardiovascular health,Frontiers in endocrinology, 4 -
[9] Chow , W. S.,Xu , A.,Woo , Y. C.,Tso , A. W.,Cheung , S. C.,Fong , C. H.,Tse , H.F.,Chau , M.T.,Cheung , B.M.,Lam , K. S.,Serum Fibroblast Growth Factor-21 Levels,Are, .Associated With Carotid Atherosclerosis Independent of Established Cardiovascular Risk FactorsSignificance, -
[10] Arteriosclerosis, 2013., 33 2454 -2459
[11] D. , Hu,C. C. , Chen,Y. , Moller,D.E. , Kharitonenkov,A., 2008.Fibroblast growth factor 21 corrects obesity in mice,Endocrinology 149 6018 -6027
[12] 2011.,Molecular cell biology 722 -
[13] Cypess , A. M.,Lehman , S.,Williams , G.,Tal , I.,Rodman , D.,Goldfine , A. B.,Kuo , F.C.,Palmer , E.L.,Tseng , Y.H.,Doria , A.,Kolodny , D.M.,Kahn , C.R., 2009.Identification and importance of brown adipose tissue in adult humans,New England Journal of Medicine 360 1509 -1517
[14] Cyphert , H. A.,Ge , X.,Kohan , A. B.,Salati , L. M.,Zhang , Y.,Hillgartner , F. B., 2012.Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21,Journal of Biological Chemistry 287 25123 -25138
[15] Díaz-Delfín , J.,Hondares , E.,Iglesias , R.,Giralt , M.,Caelles , C.,Villarroya , F., 2012.TNF-α represses β- Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway,Endocrinology 153 4238 -4245
[16] Domouzoglou , E. M.,Naka , K. K.,Vlahos , A. P.,Papafaklis , M. I.,Michalis , L. K.,Tsatsoulis , A.,Maratos-Flier , E., 2015.Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21,American Journal of Physiology-Heart and Circulatory Physiology 309 H1029 -H1038
[17] Dushay , J.,Chui , P. C.,Gopalakrishnan , G. S.,Varela-Rey , M.,Crawley , M.,Fisher , F. M.,Badman , M.K.,Martinez-Chantar , M.L.,Maratos-Flier , E., 2010.Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease,Gastroenterology 139 456 -463
[18] A., 2012.Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones,Cell 148 556 -567
[19] 2014.Myokines in insulin resistance and type 2 diabetes, 57 1087 -1099
[20] Feingold , K. R.,Grunfeld , C.,Heuer , J. G.,Gupta , A.,Cramer , M.,Zhang , T.,Shigenaga , J.K.,Patzek , S.M.,Chan , Z.W.,Moser , A.,Bina , H.,Kharitonenkov , A., 2012.FGF21 is increased by inflammatory stimuli and protects leptindeficient ob/ob mice from the toxicity of sepsis,Endocrinology 153 2689 -2700
[21] Fenzl , A.,Kiefer , F. W., 2014.Brown adipose tissue and thermogenesis,Hormone molecular biology and clinical investigation 19 25 -37
[22] 2012.FGF21 regulates PGC-539 1alpha and browning of white adipose tissues in adaptive thermogenesis,Genes & development 540 271 -281
[23] .Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets,Gastroenterology 147 1073 -1083
[24] 2014., -
[25] Gallego-Escuredo , J.,Gomez-Ambrosi , J.,Catalan , V.,Domingo , P.,Giralt , M.,Frühbeck , G.,Villarroya , F., 2015.Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients,International journal of obesity 121 -
[26] Gälman , C.,Lundåsen , T.,Kharitonenkov , A.,Bina , H. A.,Eriksson , M.,Hafström , I.,Dahlin , M.,Amark , P.,Angelin , B.,Rudling , M., 2008.The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARα activation in man,Cell metabolism 8 169 -174
[27] Gariani , K.,Drifte , G.,Dunn-Siegrist , I.,Pugin , J.,Jornayvaz , F. R.,Increased, 2013.FGF21 plasma levels in humans with sepsis and SIRS, 2 146 -153
[28] Ge , X.,Wang , Y.,Lam , K. S.,Xu , A., 2012.Metabolic actions of FGF21: molecular mechanisms and therapeutic implications,Acta Pharmaceutica Sinica B 2 350 -357
[29] 2017.Fibroblast growth factor 21 and its novel association with oxidative stress,Redox biology 11 335 -341
[30] 2008.Acanthosis nigricans: a practical approach to evaluation and management,Dermatology online journal 14 -
[31] 2011.Thermogenic activation induces FGF21 expression and release in brown adipose tissue,Journal of Biological Chemistry 286 12983 -12990
[32] Hondares , E.,Rosell , M.,Gonzalez , F. J.,Giralt , M.,Iglesias , R.,Villarroya , F.,Hepatic, .FGF21 expression is induced at birth via PPARα in response to milk intake and contributes to thermogenic activation of neonatal brown fat, -
[33] 2010.,Cell metabolism 11 206 -212
[34] MECHANISMS IN ENDOCRINOLOGY, 2012.: Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21,European Journal of Endocrinology 167 301 -309
[35] Inagaki , T., .Research perspectives on the regulation and physiological functions of FGF21 and its association with NAFLD, -
[36] .Frontiers in endocrinology, (6): 147 (, 2015) -
[37] Itoh , N., .FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases, -
[38] Frontiers in endocrinology, (5): 107 (, -2014)
[39] Itoh , N.,Ornitz , D. M., 2004.Evolution of the Fgf and Fgfr gene families,TRENDS in Genetics 20 563 -569
[40] Izumiya , Y.,Bina , H. A.,Ouchi , N.,Akasaki , Y.,Kharitonenkov , A.,Walsh , K., 2008.FGF21 is an Aktregulated myokine,FEBS letters 582 3805 -3810
[41] Jones , L. H.,Ficca , M., 2007.Is Acanthosis Nigricans a reliable indicator for risk of type 2 diabetes?,The Journal of School Nursing 23 247 -251
[42] Kharitonenkov , A., 2009.FGFs and metabolism,Current opinion in pharmacology 9 805 -810
[43] FGF-21 as a novel metabolic regulator,The Journal of clinical investigation 115 1627 -1635 2005
[44] Kharitonenkov , A.,Wroblewski , V. J.,Koester , A.,Chen , Y.-F.,Clutinger , C. K.,Tigno , X. T.,Hansen , B.C.,Shanafelt , A.B.,Etgen , G.J., .The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21., -
[45] Endocrinology, 2007., 148 774 -781
[46] 2013.Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine,Nature medicine 83 -
[47] Kim , S.,Choe , S.,Lee , D. K., 2016.BMP-9 enhances fibroblast growth factor 21 expression and suppresses obesity,Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1237 -1246
[48] Kluczynik , C. E. N.,Mariz , L. S.,Souza , L. C. F.,Solano , G. B.,Albuquerque , F. C. d. L.,Medeiros , C. C. M., 2012.Acanthosis nigricans and insulin resistance in overweight children and adolescents, 87 531 -537
[49] Krawczyk , M.,MykałaCieśla,KołodziejJaskuła , A., 2009.Acanthosis nigricans as a para neoplastic syndrome,Polskie Archiwum Medycyny Wewnętrznej 119 180 -183
[50] Laeger , T.,Henagan , T. M.,Albarado , D. C.,Redman , L. M.,Bray , G. A.,Noland , R. C.,Münzberg , H.,Hutson , S.M.,Gettys , T.W.,Schwartz , M.W.,Morrison , C.D., 2014.FGF21 is an endocrine signal of protein restriction,The Journal of clinical investigation 3913 -
[51] Li , H.,Fang , Q.,Gao , F.,Fan , J.,Zhou , J.,Wang , X.,Pan , X.,Bao , Y.,Xiang , K.,Xu , A.,Jia , W., 2010.Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride,Journal of hepatology 53 934 -940
[52] Lin , Z.,Tian , H.,Lam , K. S.,Lin , S.,Hoo , R. C.,Konishi , M.,Itoh , N.,Wang , Y.,Bornstein , S.R.,Xu , A.,Li , X., .Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice., -
[53] ,Cell metabolism 17 779 -789=2013
[54] Lin , Z.,Wu , Z.,Yin , X.,Liu , Y.,Yan , X.,Lin , S.,Xiao , J.,Wang , X.,Feng , W.,Li , X., 2010.Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile,PLoS One 5 -
[55] .Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding,Diabetes 63 4057 -4063-2014
[56] Fenretinide mediated retinoic acid receptor signalling and inhibition of ceramide biosynthesis regulates adipogenesis, lipid accumulation, mitochondrial function and nutrient stress signalling in adipocytes and adipose tissue,Biochemical pharmacology 100 86 -97-2016
[57] McMillan , A. C.,White , M. D., 2015.Induction of thermogenesis in brown and beige adipose tissues: molecular markers, mild cold exposure and novel therapies,Current Opinion in Endocrinology, Diabetes and Obesity 22 347 -352
[58] Meek , T. H.,Morton , G. J., 2016.The role of leptin in diabetes: metabolic effects,Diabetologia 59 928 -932
[59] .Fibroblast growth factor 23 and Inflammation in CKD,Clinical Journal of the American Society of Nephrology, CJN 13281211 -2012
[60] Napolitano , M.,Megna , M.,Monfrecola , G., 2015.Insulin resistance and skin diseases,The Scientific World Journal -
[61] .Identification of a novel FGF, FGF-21, preferentially expressed in the liver1, -
[62] Biochimica et Biophysica Acta (BBA)-Gene Structure, 2000., 1492 203 -206
[63] Omar , B. A.,Andersen , B.,Hald , J.,Raun , K.,Nishimura , E.,Ahrén, 2014.and Glucagon-Like Peptide 1 Contribute to Diabetes Resistance in Glucagon Receptor-Deficient Mice,Fibroblast Growth Factor 63 101 -110
[64] Peirce , V.,Vidal-Puig , A., 2013.Regulation of glucose homoeostasis by brown adipose tissue,The lancet Diabetes & endocrinology, 1 353 -360
[65] Pengfei , Xu.,Yingjie,Wenfei , Wang.,Qingyan,Zhihang,LubnaMuhi,Qiang,Mingyao,Xianlong,Deshan , Li.,Guiping, 2015.Ren. Long-Term Administration of Fibroblast Growth Factor 21 Prevents Chemically-Induced Hepatocarcinogenesis in Mice,Dig Dis Sci 60 3032 -3043
[66] Poher , A.-L.,Altirriba , J.,Veyrat-Durebex , C.,Rohner-Jeanrenaud , F., 2015.Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance,Frontiers in physiology, 6 -
[67] Oxidative stress and human health,Advances in Bioscience and Biotechnology 997 - 2012
[68] Rosen , E. D.,Spiegelman , B. M., 2006.Adipocytes as regulators of energy balance and glucose homeostasis,Nature 847 -
[69] Shenglong , Zhu.,Lei,Yunzhou,Xianlong,Tianyuan,Qingyang,LubnaMuhi,Yunye,Mo,Bing,Guiping,Deshan , Li., 2014.FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway,Acta Biochim Biophys Sin 46 1041 -1048
[70] Adiponectin, 2016.fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk,Cell metabolism 23 770 -784
[71] Stojsavljević , S.,Palčić , M. G.,Jukić , L. V.,Duvnjak , L. S.,Duvnjak , M., 2014.Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease,World journal of gastroenterology: WJG 18070 -
[72] Van Belle , T. L.,Gysemans , C.,Mathieu , C., 2013.Vitamin D and diabetes: the odd couple,Trends in Endocrinology & Metabolism 24 561 -568
[73] Lipids in health and disease 113 - 2014
[74] .Fibroblast growth factor-21 improves pancreatic β-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways, -
[75] Diabetes, 2006., 55 2470 -2478
[76] Whittle , A. J.,Carobbio , S.,Martins , L.,Slawik , M.,Hondares , E.,Vázquez , M. J.,D. , Csikasz,R.I. , Gallego,R. , Rodriguez-Cuenca,S. , Dale,M. , Virtue,S. , Villarroya,F. , Cannon,B. , Rahmouni,K. , López,M. , Vidal-Puig,A., 2012.BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions,Cell 149 871 -885
[77] Woo , Y.,Xu , A.,Wang , Y.,Lam , K. S., 2013.Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives,Clinical endocrinology 78 489 -496
[78] Xu , J.,Stanislaus , S.,Chinookoswong , N.,Lau , Y. Y.,Hager , T.,Patel , J.,Ge , H.,Weiszmann , J.,Lu , S.C.,Graham , M.,Busby , J.,Hecht , R.,Li , Y.S.,Li , Y.,Lindberg , R.,Véniant , M.M., 2009.Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse modelsassociation with liver and adipose tissue effects,American Journal of PhysiologyEndocrinology and Metabolism 297 E1105 -E1114
[79] Yang , M.,Dong , J.,H. , Li,L. , Yang,G., 2011.Effects of short-term continuous subcutaneous insulin infusion on fasting plasma fibroblast growth factor-21 levels in patients with newly diagnosed type 2 diabetes mellitus,PLoS One 6 -
[80] YeXianglong,J. , Ren,Xu , Pengfei.,Wu,Yu , Dan.,LiS,MuhiRasoul,Li, 2015.Deshan. Long-lasting antidiabetic efficacy of PEGylated FGF-21 and liraglutide in treatment of type 2 diabetic mice,Endocrine 49 683 -92
[81] Yu , Y.,Li , S.,Y. , Tian,G. , Yuan,Q. , Bai,F. , Wang,W. , Zhang,Z. , Ren,G.,Y. , Li,D., 2015.Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway,International immunopharmacology 25 74 -82
[82] T. Rezaei,N., 2013.Acanthosis nigricans, abnormal facial appearance and dentition in an insulin resistance syndrome,Iranian journal of pediatrics 363 -
[83] .Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice,Clinical Science 130 625 -641-2016
[84] Ye Xianglong, Qi, J., Ren, Guiping., Xu ,Pengfei., Wu, Yun Zhu., Yu,Dan., Li S, Wu,Qiang., Muhi Rasoul,Lubna., Li ,Deshan. Long-lasting anti-diabetic efficacy of PEGylated FGF-21 and liraglutide in treatment of type 2 diabetic mice. Endocrine. 49(3):683-92 (2015).
[85] Yu, Y., Li, S., Liu, Y., Tian, G., Yuan, Q., Bai, F., Wang, W., Zhang, Z., Ren, G., Zhang, Y., Li, D., Fibro blast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway. International immunopharmacology, 25(1): 74-82 (2015).
[86] Zaridoust, A., Rabbani, A., Sayarifard, F., Thiel, C. T.,Rezaei, N. Acanthosis nigricans, abnormal facial appearance and dentition in an insulin resistance syndrome. Iranian journal of pediatrics, 23(3): 363 (2013).
[87] Zhang, J., Cheng, Y., Gu, J., Wang, S., Zhou, S., Wang, Y., Tan, Y., Feng ,W., Fu, Y., Mellen, N., Cheng, R., Ma ,J., Zhang, C., Li, Z., Cai, L. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice. Clinical Science, 130(8): 625-641 (2016).
Citations
Citations are not available for this document.
0

Citations

0

Downloads

19

Views